Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Mena

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Translational Andrology and Urology|November 21, 2018
Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agentsMarcin Czarniecki, Esther Mena, Liza Lindenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2004
Left ventricular end-diastolic volume is decreased at maximal exercise in athletes with marked repolarisation abnormalities: a continuous radionuclide monitoring studyAlbert Flotats, Ricard Serra-Grima, Valle Camacho, et al.
Advances in Radiation Oncology|June 1, 2022
Successful Stereotactic Body Radiation Therapy for Postbrachytherapy Prostate Recurrence and Penile Bulb MetastasisDeborah E Citrin, Erica Schott, Kilian Salerno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2013
18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumorsAnish Thomas, Esther Mena, Karen Kurdziel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 21, 2014
Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomesCharles Marcus, Anthony Ciarallo, Abdel K Tahari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024
Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor Quantification and Prognosis of Cancer on PET/CTKevin H Leung, Steven P Rowe, Moe S Sadaghiani, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2018
Combined model-based and patient-specific dosimetry for <sup>18</sup>F-DCFPyL, a PSMA-targeted PET agentDonika Plyku, Esther Mena, Steven P Rowe, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Circulating Tumor Cells Are Detectable and Independent of PSA and PSMA-PET Metrics in Localized High-Risk and Biochemically Recurrent Prostate CancerShraddha Rastogi, Nahoko Sato, Sunmin Lee, et al.
Radiation Oncology (London, England)|February 11, 2021
Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniquesLindsay S Rowe, Stephanie Harmon, Adam Horn, et al.
Molecular Imaging and Biology|November 1, 2021
A Pilot Study of Dynamic <sup>18</sup>F-DCFPyL PET/CT Imaging of Prostate Adenocarcinoma in High-Risk Primary Prostate Cancer PatientsMichelle Lu, Liza Lindenberg, Esther Mena, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Translational Andrology and Urology|November 21, 2018
Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agentsMarcin Czarniecki, Esther Mena, Liza Lindenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2004
Left ventricular end-diastolic volume is decreased at maximal exercise in athletes with marked repolarisation abnormalities: a continuous radionuclide monitoring studyAlbert Flotats, Ricard Serra-Grima, Valle Camacho, et al.
Advances in Radiation Oncology|June 1, 2022
Successful Stereotactic Body Radiation Therapy for Postbrachytherapy Prostate Recurrence and Penile Bulb MetastasisDeborah E Citrin, Erica Schott, Kilian Salerno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2013
18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumorsAnish Thomas, Esther Mena, Karen Kurdziel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 21, 2014
Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomesCharles Marcus, Anthony Ciarallo, Abdel K Tahari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024
Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor Quantification and Prognosis of Cancer on PET/CTKevin H Leung, Steven P Rowe, Moe S Sadaghiani, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2018
Combined model-based and patient-specific dosimetry for <sup>18</sup>F-DCFPyL, a PSMA-targeted PET agentDonika Plyku, Esther Mena, Steven P Rowe, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Circulating Tumor Cells Are Detectable and Independent of PSA and PSMA-PET Metrics in Localized High-Risk and Biochemically Recurrent Prostate CancerShraddha Rastogi, Nahoko Sato, Sunmin Lee, et al.
Radiation Oncology (London, England)|February 11, 2021
Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniquesLindsay S Rowe, Stephanie Harmon, Adam Horn, et al.
Molecular Imaging and Biology|November 1, 2021
A Pilot Study of Dynamic <sup>18</sup>F-DCFPyL PET/CT Imaging of Prostate Adenocarcinoma in High-Risk Primary Prostate Cancer PatientsMichelle Lu, Liza Lindenberg, Esther Mena, et al.
Pageof 12